These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10706117

  • 1. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
    You L, Yang CT, Jablons DM.
    Cancer Res; 2000 Feb 15; 60(4):1009-13. PubMed ID: 10706117
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.
    Horio Y, Hasegawa Y, Sekido Y, Takahashi M, Roth JA, Shimokata K.
    Cancer Gene Ther; 2000 Apr 15; 7(4):537-44. PubMed ID: 10811471
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M, Feunteun J, Kirn DH, Vassal G.
    Cancer Res; 2002 Feb 01; 62(3):764-72. PubMed ID: 11830531
    [Abstract] [Full Text] [Related]

  • 4. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.
    Ganly I, Kim YT, Hann B, Balmain A, Brown R.
    Gene Ther; 2001 Mar 01; 8(5):369-75. PubMed ID: 11313813
    [Abstract] [Full Text] [Related]

  • 5. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C, Lemmon M, Kirn D.
    Clin Cancer Res; 2000 Dec 01; 6(12):4908-14. PubMed ID: 11156251
    [Abstract] [Full Text] [Related]

  • 6. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
    Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 1999 Sep 01; 59(17):4369-74. PubMed ID: 10485485
    [Abstract] [Full Text] [Related]

  • 7. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
    Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R.
    Gene Ther; 2000 Dec 01; 7(23):2051-7. PubMed ID: 11175318
    [Abstract] [Full Text] [Related]

  • 8. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 9. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
    Harada N, Maniwa Y, Yoshimura M, Nagata M, Hamada H, Yokono K, Okita Y.
    Oncol Rep; 2005 Nov 15; 14(5):1155-63. PubMed ID: 16211279
    [Abstract] [Full Text] [Related]

  • 10. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
    Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B.
    Oncogene; 2004 Feb 12; 23(6):1300-7. PubMed ID: 14676844
    [Abstract] [Full Text] [Related]

  • 11. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
    Steegenga WT, Riteco N, Bos JL.
    Oncogene; 1999 Sep 09; 18(36):5032-43. PubMed ID: 10490840
    [Abstract] [Full Text] [Related]

  • 12. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer].
    Fujiwara T, Inoue F, Tanaka N.
    Gan To Kagaku Ryoho; 1998 Jan 09; 25(2):194-200. PubMed ID: 9474928
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 14. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
    Rogulski KR, Freytag SO, Zhang K, Gilbert JD, Paielli DL, Kim JH, Heise CC, Kirn DH.
    Cancer Res; 2000 Mar 01; 60(5):1193-6. PubMed ID: 10728673
    [Abstract] [Full Text] [Related]

  • 15. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
    Rohr UP, Wulf MA, Stahn S, Heyd F, Steidl U, Fenk R, Opalka B, Pitschke G, Prisack HB, Bojar H, Haas R, Kronenwett R.
    Cancer Gene Ther; 2003 Dec 01; 10(12):898-906. PubMed ID: 14712316
    [Abstract] [Full Text] [Related]

  • 16. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
    Quist SR, Wang-Gohrke S, Köhler T, Kreienberg R, Runnebaum IB.
    Cancer Gene Ther; 2004 Aug 01; 11(8):547-54. PubMed ID: 15153938
    [Abstract] [Full Text] [Related]

  • 17. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT, You L, Uematsu K, Yeh CC, McCormick F, Jablons DM.
    Cancer Res; 2001 Aug 15; 61(16):5959-63. PubMed ID: 11507034
    [Abstract] [Full Text] [Related]

  • 18. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM.
    Anticancer Res; 2000 Aug 15; 20(6B):4463-71. PubMed ID: 11205289
    [Abstract] [Full Text] [Related]

  • 19. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.
    Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA.
    Cancer Res; 1994 May 01; 54(9):2287-91. PubMed ID: 8162565
    [Abstract] [Full Text] [Related]

  • 20. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
    Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R, Rochlitz C.
    Cancer Gene Ther; 2000 Sep 01; 7(9):1215-9. PubMed ID: 11023193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.